logo

TNGX

Tango Therapeutics·NASDAQ
--
--(--)
--
--(--)

TNGX fundamentals

Tango Therapeutics (TNGX) released its earnings on Mar 5, 2026: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.29 (YoY +17.14%), beat estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.29
+17.14%
Report date
Mar 5, 2026
EPS
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Q4,2025
Actual
-0.28-0.25-0.29-0.28-0.33-0.33-0.32-0.23-0.23-0.32-0.35-0.24-0.27-0.35-0.36-0.350.14-0.29
Forecast
-0.284-0.264-0.272-0.316-0.3167-0.355-0.3517-0.326-0.337-0.274-0.31-0.345-0.3667-0.338-0.3501-0.3438-0.0506-0.3182
Surprise
+1.41%
+5.30%
-6.62%
+11.39%
-4.20%
+7.04%
+9.01%
+29.45%
+31.75%
-16.79%
-12.90%
+30.43%
+26.37%
-3.55%
-2.83%
-1.80%
+376.68%
+8.86%
Revenue
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Q4,2025
Actual
6.79M5.72M5.76M5.77M6.92M6.41M5.77M14.60M10.73M5.43M6.47M19.88M11.61M4.12M5.39M3.18M53.81M0
Forecast
6.51M6.57M5.83M5.66M5.64M6.32M6.77M7.19M7.59M8.24M7.50M7.63M8.07M8.02M6.73M6.70M53.80M500.40K
Surprise
+4.32%
-13.06%
-1.31%
+1.97%
+22.64%
+1.44%
-14.83%
+103.08%
+41.40%
-34.12%
-13.76%
+160.42%
+43.90%
-48.64%
-19.84%
-52.55%
+0.02%
-100.00%

Earnings Call